Platinum Investment Management LTD Alkermes Plc. Transaction History

Platinum Investment Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$21.47 - $32.08 $1.72 Million - $2.57 Million	-80,185 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$23.37 - $32.13 $2.38 Million - $3.27 Million	-101,901 Reduced 55.96%	80,185 $2.47 Million
Q2 2021 Aug 11, 2021	BUY	$18.78 - $25.15 $363,768 - $487,155	19,370 Added 11.9%	182,086 $4.47 Million
Q2 2020 Aug 06, 2020	BUY	$13.31 - $19.41 $656,409 - $957,242	49,317 Added 43.49%	162,716 $3.16 Million
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $751,132 - $1.22 Million	57,514 Added 102.91%	113,399 $1.64 Million
Q4 2019 Feb 13, 2020	BUY	$17.29 - $21.74 $966,251 - $1.21 Million	55,885 New	55,885 $1.14 Million

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.